Clinical Trial Update: The Set-Point Study for Type 2 Diabetes: Evaluating the Use of an Insulin Only Bionic Pancreas System in Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluating an insulin-only bionic pancreas system for Type 2 diabetes, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• insulin-only bionic pancreas system

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2019-09-10